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Abstract
Obesity and related diabetes are important health threatening multifactorial metabolic diseases and it has been suggested
that 25% of all diabetic patients are unaware of their patho-physiological condition. Biomarkers for monitoring and control
are available, but early stage predictive biomarkers enabling prevention of these diseases are still lacking. We used the pig
as a model to study metabolic disease because humans and pigs share a multitude of metabolic similarities. Diabetes was
chemically induced and control and diabetic pigs were either fed a high unsaturated fat (Mediterranean) diet or a high
saturated fat/cholesterol/sugar (cafeteria) diet. Physiological parameters related to fat metabolism and diabetes were
measured. Diabetic pigs’ plasma proteome profiles differed more between the two diets than control pigs plasma proteome
profiles. The expression levels of several proteins correlated well with (patho)physiological parameters related to the fat
metabolism (cholesterol, VLDL, LDL, NEFA) and diabetes (Glucose) and to the diet fed to the animals. Studying only the
control pigs as a model for metabolic syndrome when fed the two diets showed correlations to the same parameters but
now more focused on insulin, glucose and abdominal fat depot parameters. We conclude that proteomic profiles can be
used as a biomarker to identify pigs with developing metabolic syndrome (prediabetes) and diabetes when fed a cafeteria
diet. It could be developed into a potential biomarkers for the early recognition of metabolic diseases.
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Introduction
In the modern western world with its high food availability and
preference for food with high saturated fat content, the number of
people showing signs of obesity and diabetes is increasing. Obesity
is characterized by increased fat storage in fat depots of the body.
However, fat depots differ, e.g. in gene expression regulation [1].
In itself stored fats are not detrimental to health. Fat storage is
even required for proper functioning of the adipocytes producing
leptin for regulation of satiety and adipo-chemokines for regulation
of immune function [2,3,4]. Furthermore, fatty acids have
important cellular functions including gene regulation for energy
requiring processes, energy expenditure regulation, and as
components of cell membranes and diverse proteins. However,
obesity may be a health threatening condition due to its
relationship with other metabolic syndromes, including diabetes
due to insulin resistance or insulin irresponsiveness [5], increased
blood cholesterol levels inducing atherosclerosis and related
problems of heart failure and high blood pressure. Nutrient
sensors play an important role in the regulation of energy
homeostasis [6,7]. Deregulation of energy homeostasis, may lead
to obesity and other metabolic syndromes.
The fully developed phenotypes of metabolic diseases can be
measured easily and tools have been developed for monitoring and
controlling the development of metabolic diseases – e.g. the blood
glucose level of diabetic patients is used as a biomarker to monitor
the status of insulin function and to control medication. However,
due to the interaction between the genotype and storage of fatty
acids related to obesity, the development of these health
threatening conditions is unpredictable, and early signs of the
development of the metabolic diseases are not easily recognized.
As a result approximately 25% of the (pre)diabetes patients are
unaware of their physiological condition. Instead of monitoring
the diseases and treating the consequences of the metabolic
syndromes, detection of the first signs of the development of these
diseases could help to take preventive actions and interfere with
the full development of the disease. Therefore, a new generation of
biomarkers, enabling the detection of the first signs of metabolic
changes, need to be developed. Preferentially, such biomarkers
need to be measurable in easily accessible body fluids such as
urine, saliva or blood. The application of –‘‘genome-wide’’
technologies, such as transcriptomics, proteomics and metabolo-
mics, offers exciting opportunities to discover such predictive
biomarkers for metabolic diseases [8,9,10,11]. In this paper we
applied proteomics as a high throughput methodology enabling
the screening of proteome expression profiles of blood plasma.
We have taken a first approach for the development of such
plasma-protein proteomics-based biomarkers using a validated pig
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model for metabolic syndrome and diabetes [12,13]. It is known
that a disbalance in fat metabolism and storage can be induced by
offering cafeteria food, rich in saturated fats to pig selected for
leanness for several decades [14,15]. Furthermore, physiologically,
pigs and humans show many similarities [16]. The advantage of
the use of a pig model is that metabolic syndrome can be
experimentally induced, that the experimental units can be kept
under controlled environmental and dietary conditions, and that
during all developmental stages different biological samples can be
collected for deep phenotyping. Therefore, pigs are a good model
system for studying human metabolic diseases in a time-dependent
manner. Previously, Bell et al. [17] reported on the use of
proteomic approaches for the analysis of serum protein profiles in
extremely fat miniature swine. We have used the model for
metabolic syndrome and diabetes in Yorkshire x Landrace pigs for
the detection of a new generation of biomarkers associated with
the first signs of metabolic changes related to metabolic syndromes
like diabetes. The objective of this investigation was to develop
proteomics profiles differentiating healthy pigs and pigs with signs
of early onset of metabolic syndromes, and with related insulin
resistance metabolic syndromes. The results indicate that several
peaks in the plasma proteome profile can be used as biomarkers to
detect the early onset of metabolic syndrome.
Materials and Methods
Animals and experimental development of obese and
diabetes metabolic syndromes
The performed research is in compliance with the ARRIVE
guidelines on animal research [18]. Experimental protocols
describing the management, surgical procedures, and animal care
were reviewed and approved by the ASG-Lelystad Animal Care
and Use Committee (Lelystad, The Netherlands).
Twenty-four 11 weeks old (approximately 30 kg) male York-
shire x Landrace pigs were divided in a control (N= 11) and an
experimental (N=13) group. The experimental group (N= 13)
received Streptozotocin that induces diabetes by destroying the B-
cells in the pancreas [19,20,21,22]. The diabetic pigs were checked
for blood glucose levels higher than 10 (data not shown) [12,13].
Approximately half of the animals in both groups (N= 5 for
control pigs and N=6 for Streptozotocin treated experimental
pigs) received a ‘‘cafeteria diet’’ consisting of high saturated fat,
half of the animals (N= 6 for control pigs and N=7 for
Streptozotocin treated experimental pigs) received a ‘‘Mediterra-
nean diet’’ consisting of high unsaturated fat for ten weeks. Table 1
describes the composition of the feeds. Control and diabetic pigs
were fed 2 meals per day (from 08:00 till 09:00 h and from 15:00
till 16:00) during which the pigs had ad libitum access to food with
a follow-up time of 10 weeks. Average daily feed intake was similar
in both control pig groups and the diabetic pigs fed the
Mediterranean diet (2362 vs 2261 vs 2462 MJ/day) but higher
in the diabetic pigs fed the cafeteria diet (3163 MJ/day, p,0.03
respectively). The afternoon meal, preceding the collection of
16 hours fasting plasma samples was restricted and identical for all
pigs (meal size was 6 MJ). Development of obesity and diabetes
was checked as described previously [12,13]. A number of
physiological parameters related to body weight gain, body
composition, fatness metabolism, and diabetes were measured
(Table 2) (file S1), in order to determine the physiological effects of
the different treatments and feeds given to the animals.
Physiological parameters were measured either 3 hours postpran-
dial or after 16 hours fasting as indicated in the Tables.
Sample preparation
In the eighth week blood samples were collected 3 hours
postprandial and after 16 hours of fasting and physiological
parameters were determined. At 9 weeks blood samples were
collected after 16 hours of fasting and used for plasma proteome
determination, and after 10 weeks the body composition
parameters were determined at slaugher. The physiological
parameters were analyzed as described before [12,13]. In short:
Blood samples collected in heparinized (150 USP. U. Lithium
Heparin, 10 mL Venoject, Terumo, Leuven, Belgium) or EDTA
(ethylenediaminetetraacetic acid, (0.47 mol/L EDTA, 10 mL
Venoject, Terumo, Leuven, Belgium) tubes were immediately
chilled at 0uC on water with ice, and centrifuged at 4uC for 10
minutes at 3000 rpm. Plasma aliquots were stored at -80uC for
later analyses.
Plasma glucose was analyzed with the Glucose liquiUV mono
kit (Human, Wiesbaden, Germany), plasma nonesterified fatty
acids were analyzed with the WAKO kit (Neuss, Germany) and
plasma and tissue triglycerides with a kit from Human (Wiesba-
den, Germany). Total, LDL and HDL cholesterol concentrations
in plasma were determined with liquicolor kits (Human,
Wiesbaden, Germany) and VLDL
cholesterol was calculated as total cholesterol minus LDL and
HDL cholesterol. Plasma insulin concentration was measured
Table 1. Composition of the high unsaturated fat
(Mediterranean) diet and the high saturated fat (cafeteria)
diet.
Feed components Mediterranean Diet Cafeteria Diet
Soy beans, extracted 51.3 51.3
Potato protein 50 50
Wheat gluten meal 118.3 118.3
Cellulose 100 100
Sucrose 100 100
Fructose 150 150
Native Pea starch 150 150
Animal fat (lard) 0 250
Trisun 80, high oleic sunflower oil 55.9 0
Canola 142.5 0
Cornoil 45 0
Fishoil 6.6 0
Cholesterol (extra) 0 10
Chalk marl 11 11
Monocalcium phosphate 9.9 9.9
Sodium chloride 4.7 4.7
Mineral/vitamin premixa 2 2
L-Lysine hydrochloride 2.8 2.8
Total (g/kg) 1000 1010
Gross Energy (GE; Mj/kg) 23.4 23.4
a: This vitamin and trace mineral premix contained per kg diet: vitamin A
(retinol) - 1750 IU; vitamin D3 (cholecalciferol) - 200 IU; vitamin E (tocopherol) -
11 IU; vit. K1 (phylloquinone) - 0.5 mg; vitamin B1 (thiamin) - 1.0 mg; vitamin B2
(riboflavin) - 4 mg; d-pantothenic acid - 9 mg; niacin (vitamin B3, nicotinic acid)
- 12.5 mg (available); biotin (vitamin H) - 50 mg; vitamin B12 (cyanocobalamin) -
15 mg; folic acid (folacin) - 0.3 mg; vit. B6 (pyridoxin) - 1.5 mg; choline - 400 mg;
Fe - 80 mg; Zn - 54 mg; Mn - 30 mg; Co - 0.15 mg; I - 0.14 mg; Se - 0.25 mg;
antioxidants (E310,320,321) - 50 mg; with maize starch as carrier.
doi:10.1371/journal.pone.0073087.t001
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using a Delfia assay (test kit by Perkin Elmer Life Sciences Trust by
Wallac Oy, Turku, Finland). This specific pig insulin assay was
validated using pig insulin standards, as indicated before [23].
Plasma C-reactive protein (CRP) was analyzed with a kit (CRP-
hs, Human, Wiesbaden, Germany).
To detect the proteins present in low levels in plasma, we used
ProteoMinerH (BioRad, Veenendaal, The Netherlands) performed
according to manufacturer’s recommendation. Briefly, 525 mg
Bulk Beads were swelled by rehydration with 10 ml 20% (v/v)
aqueous EtOH. One hundred ml of this beads solution was washed
with water and PBS in a 96-well filter plate (Pall-5039) and
subsequently mixed with 200 ml centrifuged EDTA plasma for two
hours at 4uC. After binding and three times washing the beads
with 200 ml PBS, the proteins were eluted three times with 20 ml of
each of the four elution reagents; fraction 1 (1 M NaCl, 20 mM
HEPES pH 7.5), fraction 2 (200 mM glycine pH 2.4), fraction 3
(60% ethylene glycol), and fraction 4 (33% isopropyl alcohol,
16.7% acetonitrile, 0.1% TFA). Between every elution the beads
were mixed for 5 minutes at room temperature, and centrifuged
1 min at 1000 g to collect the eluent from filter plate to a non-
binding collection plate (Greiner Bio-one 655900).
Proteomics
To fractionate the proteome isolates we used protein array types
H50 (a hydrophobic protein array type for lipoprotein binding
with 10% acetonitrile, 0.1% trifluoroacetic acid (TFA) binding
buffer), IMAC (a copper containing protein array type for
phosphoprotein binding with 0.1 M sodium phosphate, 0.5 M
NaCl pH 7 binding buffer), and CM10 (a weak cation exchanger
with low stringent (100 mM sodium-acetate pH 4) and high
stringent (100 mM sodium-acetate pH 7) binding buffers for
binding of electrically charged proteins). The different Pro-
teinChip arrays were equilibrated with the respective binding
buffers. One hundred ml of the 10-fold diluted fractions, in
appropriate binding buffer depending of the array (total volume
250 ml), were incubated on the ProteinChip arrays. After 60
minutes incubation with continuous shaking the arrays were
washed three times with 200 ml appropriate binding buffer,
followed by a wash with 200 ml MilliQ water. After air drying at
room temperature, 261 ml of a saturated solution of energy
absorbing matrix sinapinic acid (SPA) in 50% acetonitrile (v/v),
0.5% trifluoroacetic acid (v/v) was added.
Mass analysis of the bound proteins was performed using the
SELDI-TOF (Surface-enhanced laser desorption/ionization-time
of flight mass spectrometry) (BioRad) technology with the Protein
Chip System Series 4000 (BioRad) equipment in positive operating
mode. Mass spectra were collected by the accumulation of laser
shots at a laser energy of 3000 n J. Proteins were detected by the
m/z values of their peaks. The highest mass to acquire was set at
200,000 kDa; Focus Mass setting was 10,000 kDa. The instru-
ment was calibrated by using the All-in-one ProteinStandard II
(BioRad). The mass spectra of the proteins captured on the chips
were recorded with the PCS4000 ProteinChip array reader
(BioRad) by using ProteinChip Data Manager software 3.5.0. [24].
Statistical evaluation
The diet-related physiological traits of all four pig groups were
analyzed using ANOVA. Post-hoc comparison between groups
was done by Student-t-test. The proteomics data were analyzed
using Lucid Proteomics Software v2.0 (Bio-Rad Laboratories).
The results were evaluated for differential expression between all
four groups of pigs. The software provided for the statistical
evaluation tools. Significance levels were set to P,0.005.
Correlations between peak expression levels and metabolic
parameters were determined with the Spearman correlation test.
Multivariate data analysis (PCA) were performed using the Lucid
Proteomics Software v2.0. Next, the residuals for SELDI-TOF
peak patterns and physiological parameters were determined using
ANOVA with a Randomized Block Design with diabetes and feed
composition as independent effects.
Results
Phenotyping of the control and diabetic pigs fed the
Mediterranean or cafeteria diet
Seventy different biochemical and other parameters were
measured in blood and several organs to determine the (metabolic)
reactions of the control and diabetic pigs, and to determine their
Table 2. Plasma parameters after 16 hours fasting of control and diabetic pigs fed either the Mediterranean or cafeteria diet.
Treatment group Control Diabetic diet F-prob
Diet Mediterranean Cafeteria Mediterranean Cafeteria
Mean SEM Mean SEM Mean SEM Mean SEM lsd diet diab
Plasma glucose (mM) 5.8 0.1 5.7 0.2 13.5 1.4 17.2 1.2 2 0.06 ,0.001
Plasma Insulin (ng/mL) 0.08 0.016 0.101 0.024 0.053 0.01 0.073 0.018 0.031 0.2 0.08
Plasma triglyceride (mM) 0.16 0.02 0.15 0.02 0.42 0.14 0.36 0.16 0.2 0.72 0.04
CRP (mg/L) 16 5 16 1 14 2 21 2 5.4 0.24 0.65
NEFA (mM) 0.38 0.05 0.34 0.07 0.5 0.14 0.72 0.16 0.23 0.38 0.04
Cholesterol (mM) 2.3a 0.4 4.8a 0.7 2.2a 0.2 15.0b 3.7 3.6 ,0.001 0.01
LDL (mM) 1.2a 0.3 2.2a 0.2 1.0a 0.1 5.4b 0.9 1 0.01 ,0.001
HDL (mM) 0.6 0.1 0.8 0.1 0.8 0.1 1.3 0.2 0.3 0.01 0.03
VLDL (mM) 0.5a 0.1 1.8a 0.4 0.4a 0 8.3b 2.6 2.8 0.001 0.03
HDL/LDL (%) 0.53 0.13 0.41 0.08 0.85 0.14 0.28 0.07 0.24 0.005 0.36
HDL/Cholesterol (%) 26bc 4 19ab 4 36c 4 11a 3 12 ,0.001 0.69
The standard errors of the means (SEM), the least square differences (lsd) and p-value (F-prob) are tabulated. tabulated. Different letters a, b or c in the same row differ
statistically at p,0.05. Nb. interactions for cholesterol, LDL, VDL and HDL/Cholesterol (lsd is here diet*diabetes); F prob HDL/LDL = 0.07; lsd = 0.35.
doi:10.1371/journal.pone.0073087.t002
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adaptive metabolic reactions to the two different feed formula-
tions. The major parameters that differ significantly between the
four experimental groups are indicated in Table 2. In general,
many metabolic parameters differed between the two diets (for
detail information see file S1), although diabetic pigs differed more
between the two diets than control pigs. The control pigs and
diabetic pigs showed many similarities in their response towards
the Mediterranean diet, while the two groups showed more
different reactions to the cafeteria diet.
Proteomics profiles differentiating control and diabetic
pigs fed the Mediterranean or cafeteria diet
We observed a total of 984 protein peaks in the four fractions of
the three different protein arrays. Table 3 shows the number of
protein peaks with significant quantitative differences between the
groups of pigs in all four fractions for each of the protein arrays.
The details of all peaks are given in the file S2. Between the
experimental groups significant quantitative differences in specific
protein peaks were found with each protein-array -type and testing
condition. The number of peaks was approximately similar for all
protein arrays and testing conditions. The number of peaks per
testing conditions varied between six and 29.
While almost all parameters showed correlations to peak
expression levels of 0.5 or more, only ten parameters showed
correlations with peak expression levels higher than 0.85. These
include the parameter measurements of NEFA, triglycerides,
glucose levels, and cholesterol, LDL and VLDL. Only the latter
three showed correlations higher than 0.9, up to 0.98 (Table 4).
These high correlation values indicate a high similarity in the
protein-peak pattern between the cholesterol, LDL and VLDL
parameters, suggesting an overlap of the molecular background of
these parameters. The ANOVA model with diabetes and feed
effects explained 27% of the variance (data not shown). Using the
residuals, i.e. the effects corrected for diabetes and feed effects, the
correlations between SELDI-TOF peaks and physiological
parameters were again determined (Table 4). The results indicate
that most correlations remained similar to the original data. The
number of correlating peaks were less for some of the results
(Table 4). All correlation values are presented in file S3.
Individual protein peaks differed for their expression levels
between the experimental groups. Figure 1 shows a representative
example for the expression levels of a peak with a molecular
weight of 28537 Da in the four groups of pigs. The results showed
that in both the control and diabetic animals given the
Mediterranean diet the expression level of the protein was similar
with little variation between the animals. Cafeteria feed reduced
the expression level in both the control and diabetic pigs, but the
diabetic pigs showed larger physiological reaction effects than the
control pigs. Similar effects were seen for other protein peaks
although the specific effects differed between peaks. Other protein
peaks indicated differential expression between control and
diabetic pigs fed the Mediterranean diet. The data for all peaks
can be found in file S4.
Principal component analysis (PCA) was used to further
separate the groups based upon the results of the expression levels
of a peak in all groups of pigs. Figure 2 shows an example of a
PCA. The control and diabetic induced Mediterranean diet
groups are highly similar. The cafeteria fed groups differed clearly
from each other. The difference between the control group fed the
two diets is smaller than the difference between the diabetic pigs
fed the two diets.
Dietary effects in control pigs
PCA analysis of the four experimental groups clearly indicated
significant effects of saturated feeds in the diabetic pigs on
cholesterol, LDL, and VLDL parameters and their correlated
protein peaks. Additional peaks with high correlations were found
for glucose/insulin related parameters and for body weight
(Table 5). Surprisingly, two-group comparison comparing the
Mediterranean and cafeteria dietary effects in the control pigs
showed that the saturated fat feed affected the expression of
protein peaks related to the cholesterol, LDL, and VLDL groups,
although to lower levels compared to the four – group analysis.
Comparing the dietary effects in the two-group and four-group
analysis showed that three peaks appear in both peak lists (file S3).
Although significant, these three peaks did not reflect the highest
correlations for the cholesterol, LDL, and VLDL parameters.
Several other correlations were found for several organ fatness
traits. The residuals, i.e. the effects corrected for diabetes and feed
effects, were used to determine the correlations between SELDI-
TOF peaks and physiological parameters again (Table 5). The
results show that most of the correlations remained similar, while
the correlations related to the cholesterol and triglyceride
concentrations and plasma transport particles showed increased
numbers of correlating peaks. All obtained correlations are
indicated in file S3.
Discussion
The development of biomarkers for the early onset of
metabolic disease status without clinical signs
Biomarkers indicate the presence of a biological process, which
could be linked to the clinical manifestation of a disease [25]. In
our study we assumed that also the metabolic changes related to
metabolic diseases could be detected with biomarkers. Liotta et al.
[26] suggested that the blood reflects the ongoing physiological
state of all tissues. This could be both molecules excreted from the
cells (e.g. for signaling to other cells or as ‘‘waste’’), or via leakage
of cells. Taken together, it may be expected that plasma protein
biomarkers reflect the metabolic status of an animal or human.
Thus, it was reasonable to assume that a changed metabolic status
was also reflected in the blood plasma. Similarly, Rao et al. [10]
showed salivary proteome profile differences related to diabetes in
human. Furthermore, Doherty et al. [8] suggested that the
symptoms of many diseases may take a considerable period of time
to manifest. Thus, it may be expected that the molecular
signatures of the disease could be measurable long before the
clinical manifestation. This makes it even more important to be
able to detect the early onset changes in a metabolic disease
pathway. Biomarkers enabling to detection of the early onset of the
metabolic disease state could be used both for prevention of the
disease, or as a target for treatment. The proteomics research in
Table 3. Plasma proteome profiles comparisons.
CM10, pH 7 CM10, pH 4 H50 IMAC
Fraction 1 7 11 22 6
Fraction 2 11 20 17 13
Fraction 3 29 25 11 18
Fraction 4 9 12 6 14
Total 56 58 56 51
Number of protein peaks for each of the protein arrays showing differential
expression between the four groups of pigs. It should be noted that some of
the peaks may be similar in subsequent fractions.
doi:10.1371/journal.pone.0073087.t003
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relation to diabetes has been reviewed by Sundsten and Ortsa¨ter
[11]. Proteomic profiles have been produced of pancreatic islets,
b-cells, adipose tissue, muscle tissue, liver tissue, and blood serum.
However, all these proteome profiles represent differences between
healthy and fully diabetes metabolic status. No research into the
early onset disease status – where no clinical signs of the disease
can be observed yet - in relation to the healthy status have been
reported. It should be interesting to compare the proteome profile
differences in metabolic status between early onset and fully
developed metabolic disease status in relation to healthy status.
The question is whether the observed differences all direct into
similar directions as the observed effects in the fully developed
metabolic disease.
Pig model for metabolic syndromes studies
The biological contrast in the current experimental design was
created in a two-step procedure. In the first step chemical
treatment was used to induce diabetes in half of the experimental
pigs [12,13,23]. This creates an absolute contrast to the not-
diabetic control pigs. In the second step, feed formulations -
mainly differing in fat composition (unsaturated vs. saturated) -
were used to create biological variation within the diabetic as well
Table 4. Correlations between plasma proteome profiles and physiological parameters.
Parameter N peak correlation Residuals Peak sharing
.0.85 (.0.9)
Cholesterol during fasting 60 (25) 26 (18) all .0.9; most 0.85–0.9
VLDL during fasting a 50 (27) 29 (21) all .0.9; most 0.85–0.9
LDL during fasting b 55 (26) 23 (7) all .0.9; most 0.85–0.9
HDL/LDL 1
Triglycerids (TG) during fasting c 1 NEFA postprandial
TG postprandial 1 Glucose
TG in Kidney 1 1
NEFA during fasting d 1 1
NEFA postprandial 2 TG
Glucose during fasting 1
Glucose postprandial 2 TG postprandial
Number of peaks showing correlation .0.85 (.0.9) between protein peak expression levels and physiological parameters in control and diabetic animals fed with the
Mediterranean or cafeteria diets. The parameters were measured either 3 hours postprandial or after 16 hours fasting, where indicated. For information on the peak m/z
values see file S3. The information after calculating the residuals using a model including effects of diabetes and feed is included. Information about peak similarities is
given where appropriate. a: Very Low Density Lipoproteins; b: Low Density Lipoproteins; c: Triglycerides; d: Non Esterified Fatty Acids.
doi:10.1371/journal.pone.0073087.t004
Figure 1. Example of proteome profile differences between
control and diabetic pigs fed two diets. Control and diabetic pigs
were either fed a healthy Mediterranean diet or a cafeteria diet differing
mainly in fatty acid composition. Plasma protein profiles were
determined with a SELDI-TOF equipment and analyzed in relation to
physiological parameters. Expression levels of peak M/Z 28537, CM10
pH 7, fraction 3. Each dot represent the expression level found in a pig.
The horizontal bar represents the mean. m: Control Mediterranean diet,
¤: Control Cafeteria diet, N: Diabetes Mediterranean diet,&: Diabetes
cafeteria diet.
doi:10.1371/journal.pone.0073087.g001
Figure 2. Principal component analysis. Control and diabetic pigs
were either fed a healthy Mediterranean diet or a cafeteria diet differing
mainly in fatty acid composition. Plasma protein profiles were
determined with a SELDI-TOF equipment and analyzed in relation to
physiological parameters. Example of the principal component analysis
of peaks showing differential expression between the groups of
animals: peak M/Z 6623, CM10, pH 7, fraction 3; m: Control
Mediterranean diet, ¤: Control Cafeteria diet, N: Diabetes Mediterra-
nean diet, &: Diabetes cafeteria diet.
doi:10.1371/journal.pone.0073087.g002
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as in the control animal groups. The latter created a high saturated
fat-metabolism effect in both control and diabetic pigs, although
the effects differed between the two groups of animals. The
influence of the diets used in both control pigs and diabetes
induced pigs highlights the effect of feed composition on control
and diabetic status. The experimental design and the observed
physiological and metabolic correlations allow to find biomarkers
for the detection of early and late metabolic disease effects,
respectively related to diet composition.
The diabetic pigs showed the typical biochemical changes
related to the metabolic disorder. In this study we showed that this
is accompanied by plasma proteome profile changes, indicating a
relationship between the plasma proteome profile changes and the
metabolic disorder. Furthermore, related changes in the reaction
of the metabolic disorder to diet composition were also accom-
panied by changes in the plasma proteome profiles. Thus, these
proteome peak profiles can be regarded as potential new
biomarkers for the clinical diabetes disease. More importantly,
also in the non-diabetic control pigs we observed diet-related
changes in the proteome profiles related to the LDL, VLDL and
cholesterol levels in blood, which can be regarded as potential
early metabolic syndrome indicators of the early stages of the
metabolic syndrome induced by diet.
Proteome profiles differentiating control and diabetic
metabolic syndrome pigs
The expression levels of proteomics peaks correlated with
parameters relating specifically to cholesterol and fatty acid blood
plasma levels, and fatty acid transport vehicles. These results
showed that proteomics can potentially be used to detect the
diabetic metabolic disease status of pigs. Especially the high
correlations found for the cholesterol levels, and the LDL and
VLDL particles are interesting. Identification of the correlated
protein peaks should reveal whether they are constituents of the
protein cores of the particles or whether they are proteins with thus
far unknown functions in the metabolic syndrome. The finding of
biomarkers relating to fatty acid metabolism may not be surprising
since adipose tissue biomarkers have been observed both for
obesity and type-2 diabetes [25].
The high number of protein peaks (up to 60) suggest that more
proteins contribute to the associations. However, it should be
noted that 60 peaks not necessarily indicate 60 different proteins
since there may be some overlap of peaks between different
fractions and array types, and degradation products of proteins
will be visible as independent peaks. On the other hand, we have
no indication that (widespread) protein degradation occurred in
our samples. The peaks may be easily accessible in blood plasma
for biomarker test development.
The here reported protein peaks show differential expression in
at least one of the four groups of pigs and may therefore be
potential biomarkers to detect early onset of the metabolic
syndrome. Two main differences were found: (1) peaks showing
differential expression between control and diabetic induced pigs
fed with the Mediterranean diet, and (2) peaks showing differential
expression between control and diabetic induced pigs fed with the
cafeteria feed, with the latter group showing larger differences in
peak expression levels. This may indicate that diabetic pigs are
extremely sensitive to differences in feed composition. These pigs
may be metabolically less efficient for fat metabolism as suggested
by the correlations with a number of protein peaks relating to fatty
acid levels in the blood. The finding of potential biomarkers
showing only differential expression for the diabetic cafeteria fed
pigs as compared to all other groups of pigs may indicate that
especially diabetes pigs are vulnerable to physiological imbalanced
reactions to the unhealthy high saturated fat cafeteria feed. This
indicates that this group showed major differences in metabolism
as compared to the other groups. We conclude that this relates to
the diabetic status of the pigs.
Dietary effects in non-diabetic control pigs
In the chemically-induced-diabetes pigs the early stages of
obesity and diabetes cannot be studied. By excluding these samples
Table 5. Correlations between plasma proteome profiles and physiological parameters in control pigs fed the two diets.
Parameter Number of peaks Residuals
Body weight at slaughter 4 2
Insulin postprandial 4
Glucose postprandial 3 6
Glucose during fasting 1 1
NEFAa postprandial 2
NEFA during fasting 17
Cholesterol during fasting (includes VLDL and LDL) 1 15
VLDLb 2 21
LDLc 3 9
HDLd 1
TGe postprandial 6
TG during fasting 1
Retroperitoneal fat (g) 1
Abdominal fat depot (i.e. Omental fat) (g) 2
Retroperitoneal fat depot per kg body weight 1
Omental fat depot per kg body fat 2
Number of peaks showing correlation .0.9 between protein peak expression levels and physiological parameters in control animals fed with the Mediterranean or
cafeteria diets.a: Non Esterified Fatty Acids; b: Very Low Density Lipoproteins; c: Low Density Lipoproteins; d: High Density Lipoproteins; e: Triglycerides.
doi:10.1371/journal.pone.0073087.t005
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from the analysis we studied the early effects of saturated fats and
our results indicated that we studies in fact the early stages of diet
induced metabolic syndrome. Metabolic syndrome, and ultimately
overt diabetes may result from long time intake of an unhealthy
high saturated fat diet. In these analyses the correlations to
glucose/insulin/NEFA/cholesterol/related parameters were
found, next to body weight and abdominal fat depots. These
correlations suggest that the diet indeed induced early stages of
metabolic syndrome. But the blood glucose levels showed that
these pigs were not diabetic (yet), so this suggest that we have here
the early signs of developing metabolic syndrome, e.g. diabetes.
The correlated protein peaks may be valuable indicators of early
onset of diabetes and could be useful for the development of
biomarkers to detect early onset of diabetes. The observed
correlations with the variation in the physiological parameters
suggested that these proteins may be early indicators of the
aberrations form the normal situation of the metabolic status of the
animals. Furthermore, the correlations with the body weight and
fatness parameters suggest that developing obesity/excessive
fatness may be the causative mechanism although the animals
were not obese.
Only three peaks were shared by the 4-group and 2-group
analyses. This suggests that most correlations found using all
animals in the analysis were related to effects of full blown
diabetes, probably because of the large contrast created by the
treatment. Thus, these three peaks may specifically represent diet-
induced effects in diabetic animals and may relate to the clinical
stage of the disease. While these results clearly indicate that the
proteome of the blood plasma was changed considerably by the
diet and the metabolic syndrome, such parameters may be less
important to detect and monitor early onset of metabolic
syndrome. Therefore, it may be more interesting to focus on the
protein peaks with correlations to glucose/insulin parameters in
the analysis of the control pigs.
The road towards early recognition of the development
of human metabolic syndromes
We investigated the proteome of plasma for biomarkers that
could be used for the clinical and preclinical early detection of
diabetes and feed composition-related metabolic changes in pigs.
We concluded that proteomic biomarkers can be identified in the
plasma of pigs that are related to 1) clinical disease, 2) traditional
biochemical measurements in diabetic cases, 3) biomarkers in
clinically healthy individuals that develop the first physiologic signs
of a metabolic syndrome, e.g. diabetes, [6]) subset of latter
biomarkers overlap with protein biomarkers of clinical cases.
Thus, identified proteins in control animals fed the saturated fat
diet may be potential biomarkers to detect early onset of metabolic
syndrome or diabetic disease in humans used to identify pigs with
metabolic syndrome (prediabetes) and diabetes when fed a
cafeteria diet. In addition, the proteomic biomarkers can be used
to screen for healthy and unhealthy diets in control and diabetic
pigs, and perhaps in humans too, especially in predestined
individuals. The results of the ANOVA model showed that only
limited effects of the diabetes experiment and feed composition
were observed. Thus, most of the variation explained by the
correlations related to the metabolic syndrome effects. The
improved results for the control (i.e. not diabetic) animals only
suggest that these peaks indeed may be early indicators of the
metabolic syndrome development due to the feed composition in
the cafeteria diet fed pigs. This suggests that these biomarkers can
also be used to differentiate healthy and potentially metabolic
syndrome developing pigs. Expressional changes can be seen in
these biomarkers during the early stages of the onset of the
metabolic disease in these pigs. Such biomarkers, if similar to
human biomarkers, could be easily tested in clinical studies to
predict the metabolic status of individuals who may be in the
process of developing diabetes or obesity-related metabolic
diseases. Since humans and pigs show many physiological
similarities it may be expected that these proteomic biomarkers
are predictive in humans too [14,26]. These biomarkers may be
helpful in early detection of pre-diabetes in not-yet-ill individuals.
As a next step towards further development of biomarkers the
proteins of the peaks should be identified. This step need to be
followed by validation of the proteins using an independent group
of pigs before studies with human derived material can be
initiated.
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